ERBB2 and invasive breast carcinoma: Immune cell PD-L1 expression is also more common than tumor cell PD-L1 expression in invasive breast cancer and is associated with high-risk histological features such as tumor grade, HER2-negativity, and hormone receptor negativity29–31.